Receptor tyrosine kinase mutations: molecular indicators for therapeutic response or signposts marking important signaling pathways?
Krystal
Geoffrey W
GW
Division of Hematology/Oncology; Virginia Commonwealth University and McGuire VA Medical Center, Richmond,VA 23249, USA. gkrystal@mail2.vcu.edu
D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology*
D020794:Receptor Protein-Tyrosine Kinases